Arturo Molina, M.D., M.S., F.A.C.P.

Arturo Molina, M.D., M.S., F.A.C.P.

Chief Medical OfficeratProtagonist Therapeutics· In proxies 2024–2025

Pay in FY2025+18% from the year before · Protagonist Therapeutics stock +126.3% the same year

Arturo Molina, M.D., M.S., F.A.C.P. was paid $4.1M in FY2025 (Dec), up 18%. Protagonist Therapeutics stock rose 126.3% that year.

Pay$100 in the stock at the end of FY23 → $381
Pay is from the Summary Compensation Table of each Protagonist Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Protagonist TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role +517%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?